Sionna Therapeutics, Inc. Common Stock SION Income Statement
| FY'25 | ||
|---|---|---|
| $60.26M+5.2% | ||
| $28.72M+116% | ||
| $88.98M+26.1% | ||
| -$88.98M-26.1% | ||
| $13.71M+54.6% | ||
| -$75.27M-22.0% | ||
| -$411.53+93.7% | ||
| -$88.47M-26.7% | ||
| -$88.98M-26.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Sionna Therapeutics, Inc. Common Stock's income statement data come from?
- Every line is extracted from Sionna Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.